JPH08506116A - 閉経期愁訴の治療用ステロイド - Google Patents

閉経期愁訴の治療用ステロイド

Info

Publication number
JPH08506116A
JPH08506116A JP6517652A JP51765294A JPH08506116A JP H08506116 A JPH08506116 A JP H08506116A JP 6517652 A JP6517652 A JP 6517652A JP 51765294 A JP51765294 A JP 51765294A JP H08506116 A JPH08506116 A JP H08506116A
Authority
JP
Japan
Prior art keywords
hydroxy
alkyl
optionally
optionally substituted
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6517652A
Other languages
English (en)
Japanese (ja)
Inventor
ローゼン，フベルト・ヤン・ヨゼフ
スホツト，ローデウエイク・ピーテル・コメリス
フアン・デ・ウエルフピーテルス，イエーン・マルグレータ・レナ
Original Assignee
アクゾ・ノベル・エヌ・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクゾ・ノベル・エヌ・ベー filed Critical アクゾ・ノベル・エヌ・ベー
Publication of JPH08506116A publication Critical patent/JPH08506116A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6517652A 1993-02-08 1994-02-04 閉経期愁訴の治療用ステロイド Pending JPH08506116A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93200332 1993-02-08
EP93200332.0 1993-02-08
PCT/EP1994/000348 WO1994018224A1 (fr) 1993-02-08 1994-02-04 Steroides pour le traitement d'affections menopausiques

Publications (1)

Publication Number Publication Date
JPH08506116A true JPH08506116A (ja) 1996-07-02

Family

ID=8213615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6517652A Pending JPH08506116A (ja) 1993-02-08 1994-02-04 閉経期愁訴の治療用ステロイド

Country Status (15)

Country Link
EP (1) EP0682672A1 (fr)
JP (1) JPH08506116A (fr)
KR (1) KR100364113B1 (fr)
CN (1) CN1046735C (fr)
AU (1) AU4675897A (fr)
BR (1) BR9405825A (fr)
CA (1) CA2155532A1 (fr)
FI (1) FI114101B (fr)
HU (2) HU0102320D0 (fr)
NO (1) NO308583B1 (fr)
NZ (1) NZ261581A (fr)
PL (1) PL182901B1 (fr)
RU (1) RU2172740C2 (fr)
WO (1) WO1994018224A1 (fr)
ZA (1) ZA94715B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019512481A (ja) * 2016-03-03 2019-05-16 バイオニス、ソシエダッド、リミターダ、ウニペルソナルＢｉｏｎｉｃｅ，Ｓ．Ｌ．Ｕ １１−メチレンステロイドの製造のための方法および新規な中間体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them
PL343428A1 (en) * 1998-03-09 2001-08-13 Akzo Nobel Nv New contraceptive kit
NZ517281A (en) * 1999-09-06 2003-09-26 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
KR20030029640A (ko) 2000-07-28 2003-04-14 악조 노벨 엔.브이. 16 알파-메틸 또는 에틸 치환 에스트로겐
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
FI54128C (fi) * 1972-12-09 1978-10-10 Akzo Nv Foerfarande foer framstaellning av nya 11,11-alkylidensteroider ur oestran- och 19-norpregnanserien med foerbaettrad hormonell verkan
NL175063C (nl) * 1972-12-09 1984-09-17 Akzo Nv Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7317358A (nl) * 1973-12-19 1975-06-23 Akzo Nv Nieuwe 11(beta)-alkylsteroiden van de oestraanreeks.
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
NL8502571A (nl) * 1985-09-20 1987-04-16 Akzo Nv Steroiden met immunomodulerende eigenschappen.
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
DE59004243D1 (de) * 1990-06-14 1994-02-24 Henning Berlin Gmbh Flüssig befüllte Steckkapselpräparate.
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019512481A (ja) * 2016-03-03 2019-05-16 バイオニス、ソシエダッド、リミターダ、ウニペルソナルＢｉｏｎｉｃｅ，Ｓ．Ｌ．Ｕ １１−メチレンステロイドの製造のための方法および新規な中間体

Also Published As

Publication number Publication date
AU682170B2 (en) 1997-09-25
ZA94715B (en) 1994-10-24
PL310125A1 (en) 1995-11-27
NO308583B1 (no) 2000-10-02
HU9501940D0 (en) 1995-09-28
EP0682672A1 (fr) 1995-11-22
RU2172740C2 (ru) 2001-08-27
AU6039494A (en) 1994-08-29
FI953747A0 (fi) 1995-08-07
BR9405825A (pt) 1995-12-05
HUT72971A (en) 1996-06-28
HU0102320D0 (en) 2001-08-28
NO953089L (no) 1995-10-06
HU220615B1 (hu) 2002-03-28
CN1117735A (zh) 1996-02-28
AU4675897A (en) 1998-02-19
WO1994018224A1 (fr) 1994-08-18
FI953747A (fi) 1995-09-12
CA2155532A1 (fr) 1994-08-18
FI114101B (fi) 2004-08-13
NO953089D0 (no) 1995-08-07
CN1046735C (zh) 1999-11-24
NZ261581A (en) 1997-06-24
PL182901B1 (pl) 2002-03-29
KR100364113B1 (ko) 2003-04-08

Similar Documents

Publication Publication Date Title
EP1272504B1 (fr) Estratrienes a substitution 8beta-hydrocarbyle utilises comme oestrogenes a action selective
JP2660404B2 (ja) アルキニル基を有するフェニル基によって１１―β位置が置換された新規な１９―ノル若しくは１９―ノルＤ―ホモステロイド化合物，その製造方法及びそれを含有する組成物
CA2084431C (fr) Steroides 17-spirofuran-3'-ylidene
JPH0559918B2 (fr)
EP1169336A1 (fr) Ent-steroides utilises comme oestrogenes selectivement actifs
FI95711B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-substituoitujen 17 -(syklopropyylioksi)androst-5-eenijohdannaisten valmistamiseksi, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
TW518339B (en) 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
HU191131B (en) Process for preparing 13-alpha-alkyl-gonanes and pharmaceutical compositions containing such compounds
CA2359660A1 (fr) 16-hydroxyestratrienes servant d'oestrogenes agissant de maniere selective
US20060270845A1 (en) 16-Hydroxyestratrienes as selectively active estrogens
JP4392066B2 (ja) 避妊活性及び抗骨粗鬆症活性を有するステロイド化合物
JPH0216760B2 (fr)
JPH08506116A (ja) 閉経期愁訴の治療用ステロイド
US5710144A (en) C-11 substituted steroids for treating menopausal complaints
JP2003508541A (ja) １１位に炭化水素置換基を有する非芳香族エストロゲンステロイド
US6258803B1 (en) C-11 substituted steroids for treating menopausal complaints
JP4749550B2 (ja) アンドロゲンとしての１４β，１７α−ヒドロキシメチルアンドロスタン誘導体
JP2003534248A (ja) 選択的活性エストロゲンとしての８β−ヒドロカルビル置換エストラトリエン
AU682170C (en) Steroids for treating menopausal complaints
US4052421A (en) 13-ethinyl-steroids and processes for their manufacture
IE67321B1 (en) 14alpha, 17alpha-ethano-16alpha-hydroxy-estratrienes
JPH089633B2 (ja) 新規な１１−メチレン−エストラ−１５−エン、その製造方法及び薬剤組成物

Legal Events

Date Code Title Description
A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20050705

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20050708